Skip to content

Abbott ABT Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Artivion logo
ArtivionAORT
Merit Medical Systems logo
Merit Medical SystemsMMSI
Boston Scientific logo
Boston ScientificBSX
DexCom logo
DexComDXCM
Edwards Lifesciences logo
Edwards LifesciencesEW

Other financials

Income statement

See full
Revenue$12.6B+13.0%
Gross profit$7.3B+15.6%
Operating income$1.7B-17.5%
Net income$928.0M-47.8%
EPS (diluted)$0.53-47.5%

Balance sheet

See full
Cash & equivalents$6.8B+4.1%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$179.51B-18.3%
Enterprise value$206.76B-13.1%
P/E33.1×+17.4×
P/S3.9×-1.2×

Profitability

See full
Gross margin56.6%+0.6pp
Operating margin15.8%-1.7pp
Net margin11.6%-20.8pp
FCF margin16.3%+0.6pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Abbott’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's operating lease right-of-use assets in other assets?
Abbott (ABT) reported operating lease right-of-use assets in other assets of $1.13B in Q4 2025.
How has Abbott's operating lease right-of-use assets in other assets changed year-over-year?
Abbott's operating lease right-of-use assets in other assets increased by 4.7% year-over-year, from $1.08B to $1.13B.
What is the long-term trend for Abbott's operating lease right-of-use assets in other assets?
Over 4 years (2021 to 2025), Abbott's operating lease right-of-use assets in other assets has grown at a -0.6% compound annual growth rate (CAGR), from $1.15B to $1.13B.